Singapore markets closed
Straits Times Index
3,332.80 -10.55 (-0.32%) Nikkei
39,583.08 +241.54 (+0.61%) Hang Seng
17,718.61 +2.14 (+0.01%) FTSE 100
8,220.64 +40.96 (+0.50%) Bitcoin USD
61,343.14 +386.09 (+0.63%) CMC Crypto 200
1,279.72 -4.10 (-0.32%)
CSPC Pharmaceutical Group Ltd (CVG.HA)
Hanover - Hanover Delayed price. Currency in EUR
Add to watchlist
As of 08:07AM CEST. Market open.
| Previous close | 0.7500 |
| Open | 0.7500 |
| Bid | 0.7258 x N/A |
| Ask | 0.7676 x N/A |
| Day's range | 0.7500 - 0.7500 |
| 52-week range | 0.6248 - 0.8316 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 21 Aug 2024 - 26 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Reuters
FOCUS-China's drugmakers can't sell mRNA shots but haven't quit yet
China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a lack of revenue. Three Chinese companies - Walvax Biotechnology, CSPC Pharmaceutical Group and Stemirna Therapeutics - came up with mRNA vaccines that won limited emergency approvals in Asia. However, Walvax and CSPC are not currently manufacturing three of their China market shots, a China health official told Reuters.
© 2024 Yahoo. All rights reserved.